Immunosuppressive activity of the oncogenic purine derivative 3-hydroxyxanthine.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001859:Bone Neoplasms / Q000276:immunology*; D003348:Cortisone / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004912:Erythrocytes; D006385:Hemagglutination Inhibition Tests; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology; D051379:Mice; D009368:Neoplasm Transplantation; D051381:Rats; D012510:Sarcoma 180 / Q000276:immunology*; D012540:Scapula; D012756:Sheep; D014184:Transplantation, Homologous; D014970:Xanthines / Q000494:pharmacology*
D007166:Immunosuppressive Agents; D014970:Xanthines; D008748:Methylcholanthrene; D003520:Cyclophosphamide; D003348:Cortisone